| Abnormality Disease | Prevalence | Stressor | Locality |
|---|---|---|---|
| Early hatch | N/A | Endrin | N/A |
| Early hatch | N/A | Water-soluble fraction #2 | N/A |
| Early hatch | N/A | Water-soluble fraction #2 | N/A |
| Embryo mortality | ~16% | Kepone | N/A |
| Embryo mortality | N/A | PCB | N/A |
| Late hatch | N/A | Water-soluble fraction #2 | N/A |
| Late hatch | N/A | Water-soluble fraction #2 | N/A |
| Malformations | N/A | Kepone | N/A |
| Mortality | N/A | Kepone | N/A |
| Mortality | N/A | Endrin | N/A |
| Mortality | N/A | PCB (1254) | N/A |
| Mortality | N/A | PCB(1016) | N/A |
| Neuromuscular defects | N/A | Malathion | N/A |
| Skeletal malformations | N/A | Trifluralin | N/A |
| Stunting | N/A | Endrin | N/A |
| Stunting | N/A | Pyrethroids | N/A |